Cancer drugs

These companies develop or sell medicines that treat cancer, such as pills, antibodies and cell therapies.
+36.1%
over 6 months · S&P 500 +2.6%

Key indicators

Health
49 / 100
Fragile
Solid
Price
P/E 40
Cheap
Expensive
Up over 1 year
57 of 105
Wallets over 90 days
2 / 5 buys / sells
Buys
Sells
Health and price: against the other tags.

The 113 companies

LLY
+43.8%
JNJ
+27.4%
ABBV
+41.2%
MRK
Size: weight in the tag. Color: move over the period.
See all companies
L
Eli Lilly
LLY
33.3%
+43.8%
J
Johnson & Johnson
JNJ
16.5%
+27.4%
A
AbbVie
ABBV
12.9%
+41.2%
M
Merck
MRK
9.0%
+34.4%
A
Amgen
AMGN
6.2%
+43.5%
G
Gilead Sciences
GILD
5.2%
+31.3%
P
Pfizer
PFE
4.1%
+17.7%
B
Bristol-Myers Squibb
BMY
3.1%
+13.7%
R
Regeneron Pharmaceuticals
REGN
2.3%
+37.2%
M
Moderna
MRNA
2.2%
+355.5%
R
Revolution Medicines
RVMD
1.1%
+18.3%
I
Incyte
INCY
0.6%
+26.9%
E
Exelixis
EXEL
0.4%
+37.6%
S
Summit Therapeutics
SMMT
0.3%
−16.1%
C
Corcept Therapeutics
CORT
0.2%
+29.4%
I
ImmunityBio
IBRX
0.2%
−24.5%
C
CG Oncology
CGON
0.2%
+11.2%
E
Erasca
ERAS
0.1%
+53.1%
C
Cogent Biosciences
COGT
0.1%
−12.6%
L
Legend Biotech
LEGN
<0.1%
−36.5%
R
Relay Therapeutics
RLAY
<0.1%
+48.3%
T
Tango Therapeutics
TNGX
<0.1%
+24.0%
E
Enliven Therapeutics
ELVN
<0.1%
+18.0%
I
Iovance Biotherapeutics
IOVA
<0.1%
+124.9%
P
Parabilis Medicines
PBLS
<0.1%
C
Celcuity
CELC
<0.1%
−53.2%
I
IDEAYA Biosciences
IDYA
<0.1%
+12.8%
X
Xencor
XNCR
<0.1%
+230.6%
R
Arcus Biosciences
RCUS
<0.1%
−26.7%
B
Biohaven
BHVN
<0.1%
+57.8%
I
Immunome
IMNM
<0.1%
−10.1%
R
Recursion Pharmaceuticals
RXRX
<0.1%
+8.7%
R
Replimune Group
REPL
<0.1%
+319.3%
V
Vir Biotechnology
VIR
<0.1%
+13.3%
Z
Zymeworks
ZYME
<0.1%
+9.7%
S
SELLAS Life Sciences
SLS
<0.1%
+11.0%
P
Precigen
PGEN
<0.1%
+2.7%
N
Nurix Therapeutics
NRIX
<0.1%
−2.4%
N
Nuvation Bio
NUVB
<0.1%
−7.6%
T
Tyra Biosciences
TYRA
<0.1%
−45.9%
D
Damora Therapeutics
DMRA
<0.1%
−12.2%
I
Inhibrx
INBX
<0.1%
−23.3%
V
Verastem
VSTM
<0.1%
+89.4%
C
Corvus Pharmaceuticals
CRVS
<0.1%
−13.6%
A
Aktis Oncology
AKTS
<0.1%
−15.0%
O
Oric Pharmaceuticals
ORIC
<0.1%
−3.6%
S
Syndax Pharmaceuticals
SNDX
<0.1%
−53.3%
R
Rigel Pharmaceuticals
RIGL
<0.1%
+53.3%
O
Obsidian Therapeutics
OBX
<0.1%
A
Aura Biosciences
AURA
<0.1%
−8.1%
S
Sana Biotechnology
SANA
<0.1%
−34.2%
C
Cullinan Therapeutics
CGEM
<0.1%
−34.6%
F
Fulgent Genetics
FLGT
<0.1%
+57.1%
N
Nuvectis Pharma
NVCT
<0.1%
+83.3%
D
Delcath Systems
DCTH
<0.1%
+85.6%
K
Kura Oncology
KURA
<0.1%
−15.7%
C
Candel Therapeutics
CADL
<0.1%
−29.3%
O
Olema Pharmaceuticals
OLMA
<0.1%
−44.4%
J
Janux Therapeutics
JANX
<0.1%
−18.1%
B
Bicara Therapeutics
BCAX
<0.1%
−50.5%
A
ArriVent BioPharma
AVBP
<0.1%
−53.3%
G
Geron
GERN
<0.1%
−25.0%
C
Crescent Biopharma
CBIO
<0.1%
−29.1%
M
Monopar Therapeutics
MNPR
<0.1%
+21.5%
C
CytomX Therapeutics
CTMX
<0.1%
−43.5%
B
BlossomHill Therapeutics
BLSM
<0.1%
A
Arvinas
ARVN
<0.1%
−24.9%
R
Relmada Therapeutics
RLMD
<0.1%
−39.0%
P
Puma Biotechnology
PBYI
<0.1%
+12.3%
C
C4 Therapeutics
CCCC
<0.1%
−22.5%
F
Faeth Therapeutics
FTH
<0.1%
−50.9%
E
Eikon Therapeutics
EIKN
<0.1%
−54.9%
A
Agenus
AGEN
<0.1%
+88.0%
A
Allogene Therapeutics
ALLO
<0.1%
−58.1%
I
Immuneering
IMRX
<0.1%
−28.1%
C
Cypherpunk Technologies
CYPH
<0.1%
+72.4%
Z
Zentalis Pharmaceuticals
ZNTL
<0.1%
−58.0%
S
Sutro Biopharma
STRO
<0.1%
−74.8%
A
ALX Oncology
ALXO
<0.1%
−48.8%
F
Fate Therapeutics
FATE
<0.1%
−27.1%
I
Inovio Pharmaceuticals
INO
<0.1%
+10.0%
P
PDS Biotechnology
PDSB
<0.1%
−34.9%
C
Perspective Therapeutics
CATX
<0.1%
−75.5%
C
Corbus Pharmaceuticals
CRBP
<0.1%
−69.3%
A
Acrivon Therapeutics
ACRV
<0.1%
−18.1%
A
ABVC BioPharma
ABVC
<0.1%
−16.5%
A
Actuate Therapeutics
ACTU
<0.1%
−89.1%
A
Allarity Therapeutics
ALLR
<0.1%
−29.3%
A
AIM ImmunoTech
AIM
<0.1%
−43.2%
B
BioAtla
BCAB
<0.1%
−59.4%
A
Ascentage Pharma Group International
AAPG
−25.0%
A
Adagene
ADAG
−51.1%
A
ADC Therapeutics
ADCT
−58.8%
A
Adlai Nortye
ANL
−21.5%
A
Autolus Therapeutics
AUTL
−28.2%
A
AstraZeneca
AZN
+2.3%
B
BioNTech
BNTX
−4.4%
E
Electra Therapeutics
ETRA
G
Genmab
GMAB
+93.6%
G
GSK
GSK
+2.5%
H
HUTCHMED
HCM
+19.1%
I
Iambic Therapeutics
IAM
I
Immunocore
IMCR
+6.7%
I
Immatics
IMTX
−41.2%
J
Jazz Pharmaceuticals
JAZZ
+5.6%
N
Nanobiotix
NBTX
−40.5%
N
Novartis
NVS
+8.4%
O
BeOne Medicines
ONC
+42.0%
R
Roche Holdings
RHHBY
0.0%
T
Takeda Pharmaceutical
TAK
+29.0%
T
Telix Pharmaceuticals
TLX
−12.6%
U
UroGen Pharma
URGN
−9.0%
Z
Zai Lab
ZLAB
+19.5%